Conolidine’s analgesic effects stem from its interaction with non-opioid pain pathways. As opposed to opioids, which bind to µ-opioid receptors while in the central anxious method, conolidine modulates alternate molecular targets. A Science Improvements review found that conolidine interacts Along with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid https://michelangelou457zju8.59bloggers.com/profile